Global Glaucoma Therapeutics Market Research Report 2023

Report ID: 1988946 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Glaucoma Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Prostaglandin Analogs
        1.2.3 Beta Blockers
        1.2.4 Alpha Agonists
        1.2.5 Carbonic Anhydrase Inhibitors
    1.3 Market by Application
        1.3.1 Global Glaucoma Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Ophthalmic Clinic
        1.3.3 Hospitals
        1.3.4 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Glaucoma Therapeutics Market Perspective (2017-2028)
    2.2 Glaucoma Therapeutics Growth Trends by Region
        2.2.1 Glaucoma Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Glaucoma Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Glaucoma Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Glaucoma Therapeutics Market Dynamics
        2.3.1 Glaucoma Therapeutics Industry Trends
        2.3.2 Glaucoma Therapeutics Market Drivers
        2.3.3 Glaucoma Therapeutics Market Challenges
        2.3.4 Glaucoma Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Glaucoma Therapeutics Players by Revenue
        3.1.1 Global Top Glaucoma Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Glaucoma Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Glaucoma Therapeutics Revenue
    3.4 Global Glaucoma Therapeutics Market Concentration Ratio
        3.4.1 Global Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Glaucoma Therapeutics Revenue in 2021
    3.5 Glaucoma Therapeutics Key Players Head office and Area Served
    3.6 Key Players Glaucoma Therapeutics Product Solution and Service
    3.7 Date of Enter into Glaucoma Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Glaucoma Therapeutics Breakdown Data by Type
    4.1 Global Glaucoma Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Glaucoma Therapeutics Forecasted Market Size by Type (2023-2028)
5 Glaucoma Therapeutics Breakdown Data by Application
    5.1 Global Glaucoma Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Glaucoma Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Glaucoma Therapeutics Market Size (2017-2028)
    6.2 North America Glaucoma Therapeutics Market Size by Country (2017-2022)
    6.3 North America Glaucoma Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Glaucoma Therapeutics Market Size (2017-2028)
    7.2 Europe Glaucoma Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Glaucoma Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Glaucoma Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Glaucoma Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Glaucoma Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Glaucoma Therapeutics Market Size (2017-2028)
    9.2 Latin America Glaucoma Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Glaucoma Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Glaucoma Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Glaucoma Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Glaucoma Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Allergan
        11.1.1 Allergan Company Detail
        11.1.2 Allergan Business Overview
        11.1.3 Allergan Glaucoma Therapeutics Introduction
        11.1.4 Allergan Revenue in Glaucoma Therapeutics Business (2017-2022)
        11.1.5 Allergan Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Glaucoma Therapeutics Introduction
        11.2.4 Pfizer Revenue in Glaucoma Therapeutics Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Glaucoma Therapeutics Introduction
        11.3.4 Novartis Revenue in Glaucoma Therapeutics Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Glaucoma Therapeutics Introduction
        11.4.4 Merck Revenue in Glaucoma Therapeutics Business (2017-2022)
        11.4.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Prostaglandin Analogs
    Table 3. Key Players of Beta Blockers
    Table 4. Key Players of Alpha Agonists
    Table 5. Key Players of Carbonic Anhydrase Inhibitors
    Table 6. Global Glaucoma Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Glaucoma Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Glaucoma Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Glaucoma Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Glaucoma Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Glaucoma Therapeutics Market Share by Region (2023-2028)
    Table 12. Glaucoma Therapeutics Market Trends
    Table 13. Glaucoma Therapeutics Market Drivers
    Table 14. Glaucoma Therapeutics Market Challenges
    Table 15. Glaucoma Therapeutics Market Restraints
    Table 16. Global Glaucoma Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Glaucoma Therapeutics Market Share by Players (2017-2022)
    Table 18. Global Top Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glaucoma Therapeutics as of 2021)
    Table 19. Ranking of Global Top Glaucoma Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Glaucoma Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Glaucoma Therapeutics Product Solution and Service
    Table 23. Date of Enter into Glaucoma Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Glaucoma Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Glaucoma Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Glaucoma Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Glaucoma Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Glaucoma Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Glaucoma Therapeutics Revenue Market Share by Application (2017-2022)
    Table 31. Global Glaucoma Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Glaucoma Therapeutics Revenue Market Share by Application (2023-2028)
    Table 33. North America Glaucoma Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Glaucoma Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Glaucoma Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Glaucoma Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Glaucoma Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Glaucoma Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Glaucoma Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Glaucoma Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Glaucoma Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Glaucoma Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Allergan Company Detail
    Table 44. Allergan Business Overview
    Table 45. Allergan Glaucoma Therapeutics Product
    Table 46. Allergan Revenue in Glaucoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 47. Allergan Recent Development
    Table 48. Pfizer Company Detail
    Table 49. Pfizer Business Overview
    Table 50. Pfizer Glaucoma Therapeutics Product
    Table 51. Pfizer Revenue in Glaucoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 52. Pfizer Recent Development
    Table 53. Novartis Company Detail
    Table 54. Novartis Business Overview
    Table 55. Novartis Glaucoma Therapeutics Product
    Table 56. Novartis Revenue in Glaucoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 57. Novartis Recent Development
    Table 58. Merck Company Detail
    Table 59. Merck Business Overview
    Table 60. Merck Glaucoma Therapeutics Product
    Table 61. Merck Revenue in Glaucoma Therapeutics Business (2017-2022) & (US$ Million)
    Table 62. Merck Recent Development
    Table 63. Research Programs/Design for This Report
    Table 64. Key Data Information from Secondary Sources
    Table 65. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Glaucoma Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Prostaglandin Analogs Features
    Figure 3. Beta Blockers Features
    Figure 4. Alpha Agonists Features
    Figure 5. Carbonic Anhydrase Inhibitors Features
    Figure 6. Global Glaucoma Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. Ophthalmic Clinic Case Studies
    Figure 8. Hospitals Case Studies
    Figure 9. Ambulatory Surgical Centers Case Studies
    Figure 10. Glaucoma Therapeutics Report Years Considered
    Figure 11. Global Glaucoma Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Glaucoma Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Glaucoma Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Glaucoma Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glaucoma Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Glaucoma Therapeutics Revenue in 2021
    Figure 17. North America Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Glaucoma Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Glaucoma Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Glaucoma Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Glaucoma Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Glaucoma Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Glaucoma Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Allergan Revenue Growth Rate in Glaucoma Therapeutics Business (2017-2022)
    Figure 46. Pfizer Revenue Growth Rate in Glaucoma Therapeutics Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Glaucoma Therapeutics Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Glaucoma Therapeutics Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Pfizer
Novartis
Merck
Frequently Asked Questions
Glaucoma Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Glaucoma Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Glaucoma Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hypertension Drugs

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Gloves

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More